Panoramic and skull imaging may aid in the identification of multiple myeloma lesions (2018)
- Authors:
- Autor USP: PEREIRA, JULIANA - FM
- Unidade: FM
- DOI: 10.4317/medoral.22123
- Subjects: DIAGNÓSTICO POR IMAGEM; CRÂNIO; IMAGEM DIGITAL; MIELOMA MÚLTIPLO; NEOPLASIAS DE CABEÇA E PESCOÇO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Medicina oral patologia oral y cirugia bucal
- ISSN: 1698-6946
- Volume/Número/Paginação/Ano: v. 23, n. 1, p. E38-E43, 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
-
ABNT
FARIA, Karina-Morais e PEREIRA, Juliana. Panoramic and skull imaging may aid in the identification of multiple myeloma lesions. Medicina oral patologia oral y cirugia bucal, v. 23, n. 1, p. E38-E43, 2018Tradução . . Disponível em: https://doi.org/10.4317/medoral.22123. Acesso em: 10 jan. 2026. -
APA
Faria, K. -M., & Pereira, J. (2018). Panoramic and skull imaging may aid in the identification of multiple myeloma lesions. Medicina oral patologia oral y cirugia bucal, 23( 1), E38-E43. doi:10.4317/medoral.22123 -
NLM
Faria K-M, Pereira J. Panoramic and skull imaging may aid in the identification of multiple myeloma lesions [Internet]. Medicina oral patologia oral y cirugia bucal. 2018 ; 23( 1): E38-E43.[citado 2026 jan. 10 ] Available from: https://doi.org/10.4317/medoral.22123 -
Vancouver
Faria K-M, Pereira J. Panoramic and skull imaging may aid in the identification of multiple myeloma lesions [Internet]. Medicina oral patologia oral y cirugia bucal. 2018 ; 23( 1): E38-E43.[citado 2026 jan. 10 ] Available from: https://doi.org/10.4317/medoral.22123 - Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP versus R-CHOP in the phase 3 LYM-3002 study
- A difficult case of angioimmunoblastic T-cell lymphoma to diagnose
- Estudo de células precuroras em leucemias agudas: identificação e fator de prognóstico das proteínas Bcl-2, Bax e CD95/Fas/APO-1
- Radiographic patterns of multiple myeloma in the jawbones of patients treated with intravenous bisphosphonates
- Bortezomib (Btz) dose intensity is the strongest predictor for overall survival (OS) in mantle cell lymphoma (MCL) patients (Pts) not considered for transplantation, receiving frontline Btz plus rituximab, cyclosphosphamide, doxorubicin, and prednisone (VR-CAP) therapy in the phase 3 LYM 3002 study
- Adult T-Cell Leukemia/Lymphoma: A Clinical and Epidemiological Analysis at the Medicine School of Sao Paulo University
- Macrophage migration inhibitory factor and chemokine RANTES in young pediatric patients with congenital cardiac communications: relation to hemodynamic parameters and the presence of Down syndrome
- Disseminated histoplasmosis and erythrophagocytosis in an immunocompromised host. [Editorial]: the role of bone marrow evaluation for prompt diagnosis of invasive fungal infections
- Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma
- Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study
Informações sobre o DOI: 10.4317/medoral.22123 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
